Farca SS

Language: Spanish
References: 20
Page: 140-142
PDF size: 37.51 Kb.

Text Extraction

No abstract

REFERENCES

1. Danzinger, R.G et-al. Effect of oral chenodesoxicholic acid and bile and kinetics and biliary lipid composition in women with cholelithiasis. J Clin Invest 1973; 52: 2809-15.

2. Nathanson, MH. Et al. Mechanisms and regulation of bile secretion. Hepatol, 1991; 14:551-7.

3. Thistle, JR. Et al. Efficacy and specificity of chenodesoxicholic acid therapy for dissolving gallstones. N Engl J Med, 1978;289:665-72.

4. Bazzoli, F. Et al. Acquired gallstones opacification during cholelitholitic treatment with chenodesoxicholic, ursodeoxicolic and taurodesoxicolic acids. Am J Gastroenterol, 1995;90:978-86.

5. Anderson, JM. Chenodesoxicholic acid desaturates bile. But how ? Gastroenterology, 1979;77:1146-55.

6. Inoi, J. Et al. Effect of administration of ursodesoxicholic acid at bedtime on cholesterol saturation of hepatic bile in Japanese patients with gallstones. J Med Invest, 1998;45:115-22.

7. Iser, JH. Et al. Chenodesoxicholic acid treatment of gallstones: a follow-up report and analysis of factors influencing response of therapy. N Engl J Med, 1975; 293:378-88.

8. Maudgal, DP. Et al. A practical guide to the nonsurgical treatment of gallstones. Drugs, 1991;41:185-9.

9. Iser, JH. Et al. Resistance to chenodesoxicholic acid (CDCA) treatment in obese with gallstones. B Med J, 1979:1509-22.

10. Pereira, SP. et al. Gallstone dissolution with oral bile acid therapy. Importance of pretreatment Ct scanning and reasons for nonrespoonse. Dig Dis Sci, 1997:42;1775-80.

11. Tokio Cooperative Gallstones Study Group. Efficiency and indications of Ursodesoxicholic acid treatment for dissolving gallstones. A multicenter doble blind trial. Gastroenterology, 1980;78:542-55.

12. Kano, M. Effects of long term ursodesoxicholate administration on expression levels of secretory low-molecular-weight phopholipases A2 and mucin genes in gallbladders and biliary composition in patients with cholesterol stones. Hepatology, 1998;28:302-06.

13. Jakobs, R. et al. Fluoroscopically guided laser litotripsy versus extracorpòreal shock wave litotripsy for retained bile duct stone: a prospective randomized study. Gut., 1997;40:678-81.

14. Petrom, ML. Et al. Repeated bile acid therapy for the long-term management of cholesterol gallstones. J Hepatol, 1996;25:719-22.

15. Gamba, PG. Et al. Is there a place for medical treatment in children with gallstones ? J pediatr Surg, 1997;32:476-79.

16. Ellis, WR. Et al. Pilot study of combination treatment for gallstones with medium dose chenodesoxicholic acid an a terpene preparation. Br Med J (Clin Res Ed), 1984; 289:953-59.

17. Zhou, J. et al. Lodinated contrast medium as an aid to gallstone dissolution with methyl-tert-butyl ether: in vitro study. Radiology, 1990;1175:479-86.

18. May, GR. et al. Efficacy of bile acid therapy for gallstone dissolution: a meta-analysis of randomized trials. Aliment Pharmacol. Ther, 1993;7:139-45.

19. Tasuma, S. et al. A combination therapy with somvastatine and ursodesoxicholic acid is more effective for cholesterol gallstone dissolution than is ursodesoxicholic acid monotherapy. J Clin Gastro, 1998;26:287-100.

20. Leuschner, U. et al. Gallstone dissolution with methyl-tert-butyl ether in 120 patients: efficacy and safety. Gut, 1991;36:193-201.